The Alfred Hospital, also known as The Alfred or Alfred Hospital, is a leading tertiary teaching hospital in Melbourne, Victoria. It is the second oldest hospital in Victoria, and the oldest Melbourne hospital still operating on its original site.

There are 638 beds in The Alfred Hospital.

During the past decade, The Alfred Hospital conducted 402 clinical trials. In the 10-year time frame, 402 clinical trials started and 136 clinical trials were completed, i.e. on average, 33.8% percent of trials that started reached the finish line to date. In the past 5 years, 206 clinical trials started and 95 clinical trials were completed. i.e. 46.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Alfred Hospital" #1 sponsor was "Bayside Health" with 71 trials, followed by "Australian and New Zealand Intensive Care Research Centre" with 26 trials sponsored, "Celgene" with 26 trials sponsored, "Gilead Sciences" with 26 trials sponsored and "The Alfred" with 26 trials sponsored. Other sponsors include 503 different institutions and companies that sponsored additional 240 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Alfred Hospital" #1 collaborator was "The Alfred" with 34 trials as a collaborator, "National Health and Medical Research Council, Australia" with 32 trials as a collaborator, "Monash University" with 26 trials as a collaborator, "Merck Sharp & Dohme LLC" with 12 trials as a collaborator and "Bristol-Myers Squibb" with 9 trials as a collaborator. Other collaborators include 474 different institutions and companies that were collaborators in the rest 331 trials.

According to Clinical.Site data, the most researched conditions in "The Alfred Hospital" are "Cystic Fibrosis" (31 trials), "Multiple Myeloma" (28 trials), "Heart Failure" (25 trials), "HIV Infections" (23 trials) and "HIV" (16 trials). Many other conditions were trialed in "The Alfred Hospital" in a lesser frequency.

Most popular intervention types in "The Alfred Hospital" are "Drug" (457 trials), "Other" (73 trials), "Device" (69 trials), "Procedure" (40 trials) and "Biological" (38 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (132 trials), "Dexamethasone" (16 trials), "Azacitidine" (14 trials), "IVA" (13 trials) and "Daratumumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "The Alfred Hospital" are 648 trials for "All" genders, 23 trials for "Male" genders and 10 trials for "Female" genders.

Currently, there are 225 active trials in "The Alfred Hospital". 5 are not yet recruiting, 130 are recruiting, 82 are Active, not recruiting, and 8 are Enrolling by invitation. In total, there were 309 completed trials in The Alfred Hospital, 3 suspended trials, and 77 terminated clinical trials to date.

Out of the total trials that were conducted in The Alfred Hospital, 84 "Phase 1" clinical trials were conducted, 175 "Phase 2" clinical trials and 250 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 49 trials, and there were also 101 trials that are defined as “Not Applicable".

The Alfred Hospital has several departments that took part in Clinical trials: "Monash Alfred Psychiatry Research Centre" - 17 trials, "The Alfred Hospital Malignant Haematology & Stem Cell Transplantation Services" - 4 trials, "The Alfred Hospital, Melbourne; Thrombosis and Haemostasis Unit" - 4 trials, "Clinical Pharmacology, Alfred Hospital" - 2 trials, "The Alfred Hosp., Clinical Research - Infectious Diseases Unit CRS" - 2 trials, "Radiology Department, The Alfred" - 2 trials